Format

Send to

Choose Destination
Immunotherapy. 2018 Sep;10(12):1023-1025. doi: 10.2217/imt-2018-0084.

Monitoring immunotherapy outcomes with circulating tumor DNA.

Author information

1
Department of Medicine (Medical Oncology), Yale School of Medicine, Yale University, New Haven, CT, USA.
2
Department of Therapeutic Radiology, Yale School of Medicine, Yale University, New Haven, CT, USA.

KEYWORDS:

cell-free DNA; circulating tumor DNA; ctDNA; immune checkpoint inhibitor; immunotherapy; lung cancer

PMID:
30185140
DOI:
10.2217/imt-2018-0084
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center